User profiles for "author:Miki Fujimura"

Miki Fujimura

Department of Neurosurgery, Hokkaido University, Sapporo
Verified email at med.hokudai.ac.jp
Cited by 18489

Neuronal death/survival signaling pathways in cerebral ischemia

T Sugawara, M Fujimura, N Noshita, GW Kim, A Saito… - NeuroRx, 2004 - Elsevier
Cumulative evidence suggests that apoptosis plays a pivotal role in cell death in vitro after
hypoxia. Apoptotic cell death pathways have also been implicated in ischemic cerebral …

[HTML][HTML] The pathophysiology of moyamoya disease: an update

OY Bang, M Fujimura, SK Kim - Journal of stroke, 2016 - ncbi.nlm.nih.gov
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …

[HTML][HTML] Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene

M Fujimura, S Sonobe, Y Nishijima, K Niizuma… - Journal of …, 2014 - ncbi.nlm.nih.gov
Moyamoya disease is characterized by a progressive stenosis at the terminal portion of the
internal carotid artery and an abnormal vascular network at the base of the brain. Although …

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke

GT Manley, M Fujimura, T Ma, N Noshita, F Filiz… - Nature medicine, 2000 - nature.com
Cerebral edema contributes significantly to morbidity and death associated with many
common neurological disorders. However, current treatment options are limited to …

[HTML][HTML] A genome-wide association study identifies RNF213 as the first Moyamoya disease gene

F Kamada, Y Aoki, A Narisawa, YU Abe… - Journal of human …, 2011 - nature.com
Moyamoya disease (MMD) shows progressive cerebral angiopathy characterized by
bilateral internal carotid artery stenosis and abnormal collateral vessels. Although∼ 15% of …

Effects of extracranial–intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial

S Miyamoto, T Yoshimoto, N Hashimoto, Y Okada… - Stroke, 2014 - Am Heart Assoc
Background and Purpose—About one half of those who develop adult-onset moyamoya
disease experience intracranial hemorrhage. Despite the extremely high frequency of …

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood—brain barrier dysfunction

Y Gasche, M Fujimura… - Journal of Cerebral …, 1999 - journals.sagepub.com
During cerebral ischemia blood–brain barrier (BBB) disruption is a critical event leading to
vasogenic edema and secondary brain injury. Gelatinases A and B are matrix …

Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey

S Kuriyama, Y Kusaka, M Fujimura, K Wakai… - Stroke, 2008 - Am Heart Assoc
Background and Purpose—The objectives of the present study were to estimate an annual
number of patients with moyamoya disease in Japan and to describe the …

Early appearance of activated matrix metalloproteinase-9 and blood–brain barrier disruption in mice after focal cerebral ischemia and reperfusion

M Fujimura, Y Gasche, Y Morita-Fujimura… - Brain research, 1999 - Elsevier
Blood–brain barrier (BBB) disruption is thought to play a critical role in the pathophysiology
of ischemia/reperfusion. Matrix metalloproteinases (MMPs) are a family of proteolytic …

Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia

Y Gasche, JC Copin, T Sugawara… - Journal of Cerebral …, 2001 - journals.sagepub.com
Oxidative stress generated during stroke is a critical event leading to blood–brain barrier
(BBB) disruption with secondary vasogenic edema and hemorrhagic transformation of …